N/ARecruiting
CTSN Embolic Protection Trial
Sponsored by Icahn School of Medicine at Mount Sinai
About this study
This is a prospective, multi-center, randomized effectiveness trial of the CardioGard Embolic Protection Cannula in high-risk valve surgery patients.
Enrolling at this location
CHI St. Vincent Heart Institute
North Little Rock, Arkansas
I'm interestedThis study also enrolls at 23 other locations. See all.
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.
Trial data sourced from ClinicalTrials.gov.